Pfizer Sues Lupin, Five Other Generics Makers Over Celebrex Patent
This article was originally published in PharmAsia News
Executive Summary
Lupin Pharmaceuticals and five other makers of generic drugs are the subject of lawsuits Pfizer filed in a U.S. court, charging infringement of its patent for osteoarthritis drug Celebrex.